3D structures of non-human antibody
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 2: | Line 2: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| + | |||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| Line 167: | Line 168: | ||
**[[4qww]] - mFab + acetylcholinesterase <br /> | **[[4qww]] - mFab + acetylcholinesterase <br /> | ||
**[[4qti]] – mFab + urokinase-type plasminogen activator <br /> | **[[4qti]] – mFab + urokinase-type plasminogen activator <br /> | ||
| - | ** | + | **[[5vco]] – mFab + peptidase<br /> |
**[[4p3d]], [[4p3c]] – mFab + metalloproteinase 14<br /> | **[[4p3d]], [[4p3c]] – mFab + metalloproteinase 14<br /> | ||
**[[4ong]], [[4onf]] - mFab + amyloid-β A4 protein<br /> | **[[4ong]], [[4onf]] - mFab + amyloid-β A4 protein<br /> | ||
| Line 315: | Line 316: | ||
**[[3p0g]], [[4lde]], [[4ldl]], [[4ldo]] – LgVHH + adrenergic receptor<br /> | **[[3p0g]], [[4lde]], [[4ldl]], [[4ldo]] – LgVHH + adrenergic receptor<br /> | ||
**[[4n1h]], [[4m3k]], [[5lwf]] – LgVHH + beta-lactamase<br /> | **[[4n1h]], [[4m3k]], [[5lwf]] – LgVHH + beta-lactamase<br /> | ||
| - | **[[5m95]], [[5m94 | + | **[[5m95]], [[5m94]] – LgVHH + metal cation transporter<br /> |
**[[5h8o]] – LgVHH + ASC<br /> | **[[5h8o]] – LgVHH + ASC<br /> | ||
**[[3k3q]] – LgVHH + Botox<br /> | **[[3k3q]] – LgVHH + Botox<br /> | ||
| Line 353: | Line 354: | ||
**[[6h7o]], [[6ibl]] – cVHH + thioredoxin + adrenergic receptor<br /> | **[[6h7o]], [[6ibl]] – cVHH + thioredoxin + adrenergic receptor<br /> | ||
| - | + | }} | |
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Current revision
3D structures of Antibody
Updated on 22-February-2023
Other Fab: protein complex
